News
ProPublica: What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
Patients For Affordable Drugs is the only national patient organization focused exclusively on lowering prescription drug prices. It’s simple: Drugs don’t work if people can’t afford them.
Have you or a loved one felt the burden of drug prices?
Big Pharma's Mid-Year Money GrabRead our report
Us V Pharma: Fighting to Protect Medicare NegotiationWe are bipartisan and do not accept funding from organizations that profit from the development or distribution of prescription drugs.
Real Stories, Real People
My diabetes medicine Januvia was so expensive that I had to make tough choices to afford it. Now that its price will be lowered through the Medicare Negotiation Program in the 2022 prescription drug law, I'll be able to get this medicine more easily and consistently. This will really help me manage both my diabetes and blood cancer. This change will make a big difference for many other patients who need expensive medications too.
Steven HadfieldNorth Carolina
In the 12 years since my diagnosis of Crohn’s disease, I’ve relied on several costly medicines to manage my health, notably Stelara — which has a monthly list price of $25,000. If I were to ever lose my coverage or my health insurance changes, I would not even be able to afford even a single dose of my life-sustaining medicine. This exorbitant cost casts a shadow over my life.
Jacquie PerssonIowa
Fighting the root causes of high drug prices.
We are working to ensure the Inflation Reduction Act’s drug pricing reforms are successfully implemented and defended against ongoing pharmaceutical industry attacks.
We aim to end abusive practices that allow drug corporations to manipulate the patent system, keep prices high, and stifle access to affordable generics.
We are pushing for greater transparency and accountability from Pharmacy Benefit Managers (PBMs) to expose their role in increasing drug prices and to support and advocate for recommendations that serve patients.
We’re focused on addressing the exorbitantly high launch prices of new drugs, particularly innovative cell and gene therapies, to make sure life-saving treatments are affordable for all patients.
Stories shared from patients across all 50 states and territories.
40k letters sent to Congress from patients in 2024
10 patient advocates have met with the President to share their stories
30 new patient advocates joined our movement in 2024
Once the first 10 negotiated drug prices take effect in 2026, people with Medicare Part D are expected to save $1.5 billion in out-of-pocket costs
In coming years, Medicare negotiation will save seniors and taxpayers tens of billions of dollars
In 2025, nearly 19 million people with Medicare will save an average of about $400 per year on out-of-pocket prescription drug costs.